首页
400-620-6333
应用
选项
-
Durvalumab (anti-PD-L1)关联靶标: CD274
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1428935-60-7 -
Avelumab (anti-PD-L1)关联靶标: CD274
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 大鼠(Rat), 小鼠(Mouse), 狗(Dog), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1537032-82-8 Compound CID : 168266339IUPAC Name: See more
SMILES: See more InChIKey: YRKYEQYAGDIKGE-UHFFFAOYSA-NInChI: See more -
Tocilizumab (anti-IL-6R)
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 375823-41-9IUPAC Name: 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diolSMILES: C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)OInChIKey: LUKBXSAWLPMMSZ-OWOJBTEDSA-NInChI: 1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+ -
Infliximab (anti-TNF-alpha)关联靶标: TNF
- 简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 170277-31-3 -
Obinutuzumab (anti-CD20)关联靶标: MS4A1
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 949142-50-1 -
Cemiplimab (anti-PD-1)关联靶标: PDCD1
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG4
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1801342-60-8 -
Camrelizumab (anti-PD-1)关联靶标: PDCD1
- 简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG4SP; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1798286-48-2 -
Secukinumab (anti-IL-17A)关联靶标: IL17A
- 简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 恒河猴(Rhesus monkey), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1229022-83-6 -
Daratumumab (anti-CD38)关联靶标: CD38
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 恒河猴(Rhesus monkey), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 945721-28-8 -
Recombinant Human FGF basic/FGF2/bFGF ProteinCAS号: 62031-54-3分子式: 分子量: 17kD
- 种属: 人(Human)
- Accession #: P09038
- 表达系统: 水稻(Oryza sativa)
- 蛋白标签: No tag
- 内毒素水平: <1.0 EU/μg
- 生物活性: Measured in a cell proliferation assay using BALB/3T3 mouse embryo fibroblasts cell line. The ED₅₀ for this effect is typically <1 ng/mL.
-
Recombinant Human EGF ProteinCAS号: 62253-63-8 Compound CID : 16143379分子式: C270H401N73O83S7 分子量: 6.5kD
- 种属: 人(Human)
- Accession #: P01133
- 表达系统: 毕赤酵母
- 蛋白标签: No tag
- 内毒素水平: <1.0 EU/mg
- 生物活性: Measured in a cell proliferation assay using BALB/3T3 mouse embryo fibroblasts cell line. The ED₅₀ for this effect is typically <1 ng/mL.
IUPAC Name: See more SMILES: See more InChIKey: GVUGOAYIVIDWIO-UFWWTJHBSA-NInChI: See more -
Recombinant Human VEGF ProteinCAS号: 127464-60-2分子式: 分子量: 19.2 kD(单体)
- 种属: 人(Human)
- Accession #: P15692-4
- 表达系统: 水稻(Oryza sativa)
- 蛋白标签: No tag
- 内毒素水平: <0.2 EU/μg
- 生物活性: The ED50 value was lower than 10.0 ng/ml, that is, the corresponding active unit was greater than or equal to 1 x 10^5 units/mg by primary HUVECs cell proliferation method.
